Vascular Disease in the Metabolic Syndrome: Do We Need to Target the Microcirculation to Treat Large Vessel Disease?

Publisher： Karger

E-ISSN： 1423-0135|46|6|515-526

ISSN： 1018-1172

Source： Journal of Vascular Research, Vol.46, Iss.6, 2009-06, pp. : 515-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The metabolic syndrome and cardiovascular disease

By Bonora Enzo  

Annals of Medicine, Vol. 38, Iss. 1, 2006-03 ,pp. : 64-80

Informa Healthcare

Access to resources Recommend Favorite

A practice ISWT is needed for ILD

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 3, 2015-04 ,pp. : 434-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: Do We Need a Disease‐Specific Cardiovascular Risk Calculator for Patients With Rheumatoid Arthritis?

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 8, 2015-05 ,pp. : 1990-1994

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sphingolipids in atherosclerosis: a metabolic underpinning of vascular disease

By Rekhter Mark   Karathanasis Sotirios  

Future Lipidology, Vol. 1, Iss. 5, 2006-10 ,pp. : 605-614

Future Medicine

Access to resources Recommend Favorite

CNTF: a target therapeutic for obesity-related metabolic disease?

By Matthews Vance   Febbraio Mark  

Journal of Molecular Medicine, Vol. 86, Iss. 4, 2008-04 ,pp. : 353-361

Springer Publishing Company

Access to resources Recommend Favorite